Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DENOSUMAB Cause Red blood cell sedimentation rate abnormal? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Red blood cell sedimentation rate abnormal have been filed in association with DENOSUMAB (Bilprevda). This represents 0.0% of all adverse event reports for DENOSUMAB.

7
Reports of Red blood cell sedimentation rate abnormal with DENOSUMAB
0.0%
of all DENOSUMAB reports
0
Deaths
2
Hospitalizations

How Dangerous Is Red blood cell sedimentation rate abnormal From DENOSUMAB?

Of the 7 reports, 2 (28.6%) required hospitalization.

Is Red blood cell sedimentation rate abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DENOSUMAB. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does DENOSUMAB Cause?

Off label use (34,612) Death (16,545) Osteonecrosis of jaw (8,438) Arthralgia (5,890) Pain in extremity (4,541) Back pain (4,465) Pain (4,102) Product storage error (3,621) Fall (3,322) Fatigue (3,009)

What Other Drugs Cause Red blood cell sedimentation rate abnormal?

ETANERCEPT (1,590) METHOTREXATE (1,445) ABATACEPT (1,444) HYDROXYCHLOROQUINE (1,388) ADALIMUMAB (1,320) TOCILIZUMAB (1,301) LEFLUNOMIDE (1,181) INFLIXIMAB (855) SULFASALAZINE (849) TOFACITINIB (625)

Which DENOSUMAB Alternatives Have Lower Red blood cell sedimentation rate abnormal Risk?

DENOSUMAB vs DEOXYCHOLIC ACID DENOSUMAB vs DEPAKINE CHRONO DENOSUMAB vs DEPAKOTE DENOSUMAB vs DEPO-PROVERA DENOSUMAB vs DERMATOPHAGOIDES FARINAE

Related Pages

DENOSUMAB Full Profile All Red blood cell sedimentation rate abnormal Reports All Drugs Causing Red blood cell sedimentation rate abnormal DENOSUMAB Demographics